1,4-dihydropyridine has been researched along with Cancer of Ovary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arora, KK; Diedrich, K; Katzur, AC; Ortmann, O; Schultze-Mosgau, A; Stojilkovic, SS | 1 |
1 other study(ies) available for 1,4-dihydropyridine and Cancer of Ovary
Article | Year |
---|---|
Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells.
Topics: Adenosine Triphosphate; Calcium; Calcium Channel Blockers; Cell Division; Dihydropyridines; Enzyme Activation; Enzyme Inhibitors; Female; Glycerophospholipids; Humans; Nifedipine; Ovarian Neoplasms; Phospholipase D; Potassium; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Thapsigargin; Tumor Cells, Cultured; Uridine Triphosphate | 2000 |